Table 1.
Baseline Characteristics of Patients Enrolled to the Study
| Clinical Features | Overall |
|---|---|
| Age, mean ± SD, years | 47.63 ± 15.6 |
| Gender, n (%) | |
| Male | 319 (53) |
| Female | 280 (47) |
| Underlying comorbidities, n (%) | 149 (24.8) |
| Hypertension | 67 (11) |
| Endocrine disease | 40 (6.7) |
| Cardiovascular disease | 18 (3) |
| Chronic lung disease | 9 (1.5) |
| Digestive disease | 20 (3.3) |
| Renal disease | 7 (1.2) |
| Tumor | 3 (0.5) |
| Cerebrovascular/nervous disease | 7 (1.2) |
| Immune disorder | 8 (1.3) |
| Others | 35 (5.8) |
| Signs or Symptoms, n (%) | |
| Fever | 379 (63.1) |
| Cough | 301 (50.1) |
| Expectoration | 6 (1.0) |
| Hemoptysis | 2 (0.3) |
| Dyspnea | 56 (9.3) |
| Catarrh | 9 (1.5) |
| Fatigue | 128 (21.3) |
| Anorexia | 3 (0.5) |
| Nausea/emesis | 14 (2.3) |
| Myalgia | 47 (7.8) |
| Dizziness/headache | 37 (6.2) |
| Pharyngalgia | 9 (1.5) |
| Abdominal pain/diarrhea | 7 (0.2) |
| Laboratory Findings, mean ± SD | |
| White blood cell count, 109/L | 6.02 ± 15.98 |
| Lymphocyte count, 109/L | 1.25 ± 1.22 |
| Neutrophil count, 109/L | 3.64 ± 2.73 |
| Erythrocyte sedimentation rate, mm/h | 43.75 ± 28.86 |
| C-reactive protein, mg/L | 25.24 ± 28.92 |
| Procalcitonin, ng/mL | 0.91 ± 7.58 |
| D-dimer, μg/mL | 68.26 ± 515.42 |
| Alanine aminotransferase, U/L | 25.54 ± 15.47 |
| Aspartate aminotransferase, U/L | 29.5 ± 16.15 |
| Total bilirubin, μmol/L | 13.56 ± 8.09 |
| Albumin, g/L | 39.75 ± 9.28 |
| Lactate dehydrogenase, U/L | 229.5 ± 118.41 |
| Blood urea nitrogen, mmol/L | 5.29 ± 3.34 |
| Serum creatinine, μmol/L | 62.52 ± 34.39 |
| Prothrombin time, s | 13.27 ± 3.34 |
| Lactic acid, mmol/L | 271.37 ± 359.03 |
| Creatine kinase, U/L | 110.23 ± 118.38 |
| SpO2, % | 93.93 ± 14.69 |